4-(3-(2,6-difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrazolo[3,4-b]pyridin-5-yl)-N-(2,3-dihydroxypropyl)benzamide

ID: ALA4793605

Chembl Id: CHEMBL4793605

PubChem CID: 139369665

Max Phase: Preclinical

Molecular Formula: C26H25F2N5O6S

Molecular Weight: 573.58

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(C(=O)NCC(O)CO)cc4)cc23)c1F

Standard InChI:  InChI=1S/C26H25F2N5O6S/c1-2-9-40(38,39)33-20-8-7-19(27)21(22(20)28)24(36)23-18-10-16(11-29-25(18)32-31-23)14-3-5-15(6-4-14)26(37)30-12-17(35)13-34/h3-8,10-11,17,33-35H,2,9,12-13H2,1H3,(H,30,37)(H,29,31,32)

Standard InChI Key:  DFLAUZQTMHLJTJ-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA4793605

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 573.58

Molecular Weight (Monoisotopic): 573.1494

AlogP: 2.37

#Rotatable Bonds: 11

Polar Surface Area: 174.37

Molecular Species: NEUTRAL

HBA: 8

HBD: 5

#RO5 Violations: 1

HBA (Lipinski): 11

HBD (Lipinski): 5

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 8.78

CX Basic pKa: ┄

CX LogP: 1.38

CX LogD: 1.37

Aromatic Rings: 4

Heavy Atoms: 40

QED Weighted: 0.17

Np Likeness Score: -1.32

References

1.  (2019)  Protein kinase mkk4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death, 

2. Juchum M, Pfaffenrot B, Klövekorn P, Selig R, Albrecht W, Zender L, Laufer SA..  (2022)  Scaffold modified Vemurafenib analogues as highly selective mitogen activated protein kinase kinase 4 (MKK4) inhibitors.,  240  [PMID:35868124] [10.1016/j.ejmech.2022.114584]

Source

Source(2):

• Scientific Literature
• Patent Bioactivity Data